NO330061B1 - Farmasoytisk medikament og anvendelse derav for forebyggelse av colorektal kreft - Google Patents

Farmasoytisk medikament og anvendelse derav for forebyggelse av colorektal kreft Download PDF

Info

Publication number
NO330061B1
NO330061B1 NO20021437A NO20021437A NO330061B1 NO 330061 B1 NO330061 B1 NO 330061B1 NO 20021437 A NO20021437 A NO 20021437A NO 20021437 A NO20021437 A NO 20021437A NO 330061 B1 NO330061 B1 NO 330061B1
Authority
NO
Norway
Prior art keywords
calcium
cancer
asa
effect
vitamin
Prior art date
Application number
NO20021437A
Other languages
English (en)
Norwegian (no)
Other versions
NO20021437D0 (no
NO20021437L (no
Inventor
Hans Henrik Raskov
Original Assignee
Colotech As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colotech As filed Critical Colotech As
Publication of NO20021437D0 publication Critical patent/NO20021437D0/no
Publication of NO20021437L publication Critical patent/NO20021437L/no
Publication of NO330061B1 publication Critical patent/NO330061B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO20021437A 1999-09-29 2002-03-22 Farmasoytisk medikament og anvendelse derav for forebyggelse av colorektal kreft NO330061B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901390 1999-09-29
PCT/DK2000/000546 WO2001022974A1 (en) 1999-09-29 2000-09-29 Prevention of colorectal cancer

Publications (3)

Publication Number Publication Date
NO20021437D0 NO20021437D0 (no) 2002-03-22
NO20021437L NO20021437L (no) 2002-05-24
NO330061B1 true NO330061B1 (no) 2011-02-14

Family

ID=8104340

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021437A NO330061B1 (no) 1999-09-29 2002-03-22 Farmasoytisk medikament og anvendelse derav for forebyggelse av colorektal kreft

Country Status (13)

Country Link
US (1) US7851461B2 (de)
EP (1) EP1220676B1 (de)
AT (1) ATE294585T1 (de)
AU (1) AU779996B2 (de)
CA (1) CA2385755C (de)
DE (1) DE60019947T2 (de)
DK (1) DK1220676T3 (de)
ES (1) ES2240159T3 (de)
IS (1) IS2488B (de)
NO (1) NO330061B1 (de)
NZ (1) NZ517978A (de)
PT (1) PT1220676E (de)
WO (1) WO2001022974A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
ES2240159T3 (es) 1999-09-29 2005-10-16 Colotech A/S Prevencion del cancer colorrectal.
US20040071789A1 (en) * 2002-02-14 2004-04-15 Baron John A Calcium supplementation to reduce prostate cancer risk
DE60233869D1 (de) * 2001-04-05 2009-11-12 Colotech As Prävention von epithelzellkarzinom
US7094775B2 (en) 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
WO2011024208A1 (en) * 2009-08-24 2011-03-03 Colotech A/S Combination dosage form with acetylsalicylic acid, calcitriol and calcium
EP2695617B1 (de) * 2009-12-23 2019-01-09 Glycomyr Inc. Vitamin D Glycoside und Sulfate zur Behandlung von Darmerkrankungen
CA2865424A1 (en) 2011-02-28 2012-09-07 Rigshospitalet Copenhagen University Hospital Active vitamin d or analogs thereof for use in in vivo or in vitro fertilization

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0205025A1 (de) 1985-05-27 1986-12-17 Sumitomo Pharmaceuticals Company, Limited Fluorin enthaltende Vitamin-D3-Derivate und Zelldifferenzierung induzierende Mittel, die sie als aktiven Wirkstoff enthalten
KR0144358B1 (ko) 1988-04-21 1998-07-15 피. 라이달 크리스텐슨 비타민 d 동족체
EP0614455B1 (de) 1991-11-07 1996-02-21 Research Institute For Medicine And Chemistry Inc. Amid derivate von vitamin d
GB9206648D0 (en) 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
GB9226877D0 (en) 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Chemical compounds
GB9309422D0 (en) 1993-05-07 1993-06-23 Res Inst Medicine Chem Chemical compounds
GB9314400D0 (en) 1993-07-12 1993-08-25 Leo Pharm Prod Ltd Produktionsaktieselskab) chemical compounds
GB9315253D0 (en) 1993-07-23 1993-09-08 Res Inst Medicine Chem Chemical compounds
DE4334154C2 (de) 1993-10-01 1997-05-22 Schering Ag 2-Halogeno-1,25-dihydroxy-cholecalciferole und pharmazeutische Zusammensetzungen
WO1996041645A1 (en) 1995-06-12 1996-12-27 G.D. Searle & Co. Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations
US5948443A (en) 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
US5770215A (en) * 1997-01-06 1998-06-23 Moshyedi; Emil Payman Multivitamin/vascular occlusion inhibiting composition
ES2240159T3 (es) 1999-09-29 2005-10-16 Colotech A/S Prevencion del cancer colorrectal.

Also Published As

Publication number Publication date
EP1220676B1 (de) 2005-05-04
CA2385755A1 (en) 2001-04-05
DE60019947D1 (de) 2005-06-09
US7851461B2 (en) 2010-12-14
ES2240159T3 (es) 2005-10-16
DE60019947T2 (de) 2006-02-02
PT1220676E (pt) 2005-08-31
AU7406300A (en) 2001-04-30
IS6317A (is) 2002-03-20
NO20021437D0 (no) 2002-03-22
ATE294585T1 (de) 2005-05-15
EP1220676A1 (de) 2002-07-10
CA2385755C (en) 2007-02-06
NO20021437L (no) 2002-05-24
AU779996B2 (en) 2005-02-24
NZ517978A (en) 2003-11-28
IS2488B (is) 2008-12-15
WO2001022974A1 (en) 2001-04-05
US20040116393A1 (en) 2004-06-17
DK1220676T3 (da) 2005-09-05

Similar Documents

Publication Publication Date Title
Arber et al. Chemoprevention of colorectal neoplasia: the potential for personalized medicine
Siddiqui et al. Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects
Saldanha et al. The role of nutraceuticals in chemoprevention and chemotherapy and their clinical outcomes
Teixeira et al. Primary prevention of colorectal cancer: myth or reality?
Piazuelo et al. NSAIDS and gastrointestinal cancer
NO330061B1 (no) Farmasoytisk medikament og anvendelse derav for forebyggelse av colorektal kreft
Kim et al. Dietary intervention for preventing colorectal cancer: a practical guide for physicians
Shokri et al. Comparison of the complications of platinum-based adjuvant chemotherapy with and without ginger in a pilot study on ovarian cancer patients
US6703380B2 (en) Prevention of cancer
WO2014093313A1 (en) Compositions and methods for integrated metabolic interventions
Elena et al. Curcumin's Therapeutic Potential in Ovarian Cancer: Current Insights and Future Perspectives
Krishnan et al. Cancer chemoprevention: A new way to treat cancer before it happens
Morris et al. Natural agents used in chemoprevention of aerodigestive and GI cancers
Umar et al. Chemoprevention of colorectal carcinogenesis
Jafrin et al. Clinically investigated natural products against prostate cancer, with mechanistic insights
AU2002338311B2 (en) A combination dosage of a cyclooxygenase (COX) inhibitor, a vitamin D3 including analogues and metabolites thereof and/or calcium for prevention of epithelial cancer
Patel et al. Does oral lycopene reduce benign prostate enlargement/hyperplasia (BPE/BPH)
Luers Prevention and Treatment of Colorectal Cancer with Turmeric and Its Main Active Constituent, Curcumin
Kowalczyk et al. The effect of low doses of Aspirin on the occurrence of rectal aberrant crypt foci (ACF)
Moshkowitz et al. Cyclo-oxygenase-2 inhibitors in colorectal cancer prevention
Costello et al. Annual Bibliography of Significant Advances in Dietary Supplement Research 2001
J Jacobs et al. Chemoprevention of Colorectal Cancer: Progress or Pipedream?
Gunter-Ward Comparative Study of Conventional and Alternative Treatments in Prostate Cancer
AU2002338311A1 (en) A combination dosage of a cyclooxygenase (COX) inhibitor, a vitamin D3 including analogues and metabolites thereof and/or calcium for prevention of epithelial cancer
Shiravi et al. Cellular and Molecular Perspective

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT POSTBOKS 1003 SENTRUM OSLO, 0

MM1K Lapsed by not paying the annual fees